p 0.05) between reduced
C. acnes bacteria and improvement in acne occurrence, and overall skin health. The randomized, controlled trial tested for three end goals: if phage reduced
C. acnes on the skin; if the
C. acnes reduction resulted in blemish control; and if this balancing of the microbiome made skin healthier.
Ninety subjects between the ages of 12 and 35 participated for eight weeks to compare the acne prevalence of skin treated with Phyla s Phortify Probiotic Serum containing phage to a placebo group of skin not treated with phage. After eight weeks, subjects treated with phage showed improved Investigator Global Assessment (IGA) scores, compared with the placebo arm (
Phyla Announces Results Of Acne Clinical Trial Demonstrating The Power of Live Probiotic Phage
Results Show Live Probiotic Naturally Found On Skin Reduces C. acnes Bacteria by 17%
News provided by
Share this article
Share this article
SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/ Phyla announced the release of results from a clinical study for its Phortify Probiotic Serum containing the brand s flagship probiotic live phage. Phyla is a brand of Phi Therapeutics, Inc., a venture-backed microbiome startup based in San Francisco co-founded by Yug Varma and Maria Cho, whose mission is to change the way society treats chronic bacterial diseases like acne. Results indicate a causal link (p 0.05) between reduced